{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-062733","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2025-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.724294+00:00","generated_at":"2026-05-22T23:00:02.926536+00:00","sec_items":["1.01","5.03","3.02","3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tivic Health enters up to $8.4M Series B Preferred financing with Helena Global","bullets":["Up to $8.4M from sale of Series B Non-Voting Convertible Preferred at $1,000/share plus warrants for common stock.","Six tranche closings: initial $700k, then $700k, then $1.75M each for four more; warrants cover 30% of underlying common.","Series B Preferred: 10% cumulative annual dividend, convertible at 90% of 5-day VWAP (floor $1.294).","Registration rights: Company to file resale registration statement within 15 days for conversion and warrant shares.","Stockholder approval required for second tranche and beyond; Exchange Cap of 19.99% of outstanding common."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-062733","json":"https://secwatch.observer/filing/0000950170-25-062733.json","markdown":"https://secwatch.observer/filing/0000950170-25-062733.md","text":"https://secwatch.observer/filing/0000950170-25-062733.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000095017025062733/0000950170-25-062733-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000095017025062733/tivc-20250429.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T23:00:02.926536+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}